COMPASSIONATE ACCESS & CLINICAL TRIALS

COMPASSIONATE ACCESS

Upon request of a Health Care Professional (HCP) and with the approval from ANSM, lntsel Chimos provides compassionate access ta drugs that do not have a marketing authorization (MA) in France to allow HCP ta treat rare or serious pathologies that have reached a therapeutic impasse.

INTSEL CHIMOS GUARANTEES...

CLINICAL STUDIES DISTRIBUTION

As part of its commitment to early access to innovation, lntsel Chimos is authorized to distribute products intended for human experimentation. This delicate operation requires specific expertise and is deeply embedded in ail stages of our supply chain.

CONDITIONS & TRACEABILITY

Intsel Chimos team takes every precaution to handle and manage these sensitive products within their own strict regulatory framework.

QUALITY GUARANTEE

We are committed to supporting clinical studies sponsors throughout the duration of their trials, in particular by quaranteeing the quality of the handling, storage, safety and traceability of their products.

EXPERIENCE & INVOLVEMENT

Based on our involvement in treating patients, our knowledge of AAC, and our experience on the French market, we are the partner of choice for pharmaceutical companies in their market access process, depending on the development phase of their pharmaceutical products.

PHASES OF A CLINICAL STUDIES

You wish to be accompanied in clinical studies or to import/export a treatment to France or Europe ?

contact@intselchimos.com
+33 1 49 11 66 80
Contact Us
CONTACT